BlackbirdAnalytics
BlackbirdAnalytics
Send Message
BlackbirdAnalytics
Stop FollowingBlackbirdAnalytics
View as an RSS Feed
- StemCells Inc: CEO Martin McGlynn Is Building A Blockbuster Company
- Trading Athersys: Risks And Rewards
-
OncoGenex: A Cancer Biotech Worth Betting On
-
A Candid Conversation With Athersys CEO Gil Van Bokkelen
-
Athersys: A Significantly Undervalued Stem Cell Company Approaching Key Catalysts
- Trading Allon Therapeutics: Risks And Rewards
- Straight Talk From Allon Therapeutics CEO Gordon McCauley
